drugset / Trial / NCT01146860

Efficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute Rhinosinusitis

NCT01146860 ↗

Phase 3 Completed 386 enrolled Bionorica SE
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether the dry extract BNO 1016 is effective and safe in the treatment of acute rhinosinusitis in adults.

Timeline

Start
2010-01
Primary completion
2010-04
Completion
2010-04

Outcome

Met primary endpoint

paper Treatment resulted in clinically relevant, significant differences in mean MSS for BNO 1016 versus placebo. PMID 23193534 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject BNO 1016 Traditional medicine (herbal / TCM) 480 mg Oral

Indications